参考文献/References:
[1]张爽爽,夏庆民,郑荣寿,等.中国2010年卵巢癌发病与死亡分析[J].中国肿瘤,2016(03):169-173.
[2]王晨,陈小岩,陈新,等.卵巢浆黏液性癌的临床病理分析[J].临床与实验病理学杂志,2015(11):1253-1257.
[3]Zhang W,Huang N,Wang Q,et al.Effect of CXCL1 gene expression on the biological function of epithelial ovarian carcinoma cells in vitro[J].Chinese Journal of Oncology,2013,35(2):109-113.
[4]Sagawa K,Uwa N,Daimon T,et al.Expression of CD44 variant isoforms,CD44v3 and CD44v6,are associated with prognosis in nasopharyngeal carcinoma[J].J Laryngol Otol,2016,130(9):843-849.
[5]纪晓宁,丰有吉.上皮性卵巢癌病因学研究进展[J].中国癌症杂志,2014(11):861-864.
[6]He M,Wang D,Zou D,et al.Re-purposing of curcumin as an anti-metastatic agent for the treatment of epithelial ovarian cancer:in vitro model using cancer stem cell enriched ovarian cancer spheroids[J].Oncotarget,2016,7(52):86374-86387.
[7]Buommino E,Di Domenico M,Paoletti I,et al.AlphaVBeta5 integrins mediates Pseudomonas fluorescens interaction with A549 cells[J].Front Biosci(Landmark Ed),2014,19:408-415.
[8]雷燕,吴绪峰.CD44基因在卵巢癌中的表达及其与预后的关系[J].医学综述,2013(01):155-158.
相似文献/References:
[1]李 俊,李春英.CD44v4在乳腺浸润性导管癌中的表达及
其与浸润转移的关系[J].医学信息,2019,32(11):95.[doi:10.3969/j.issn.1006-1959.2019.11.025]
LI Jun,LI Chun-ying.Expression of CD44v4 in Breast Invasive Ductal Carcinoma and
Its Relationship with Invasion and Metastasis[J].Journal of Medical Information,2019,32(04):95.[doi:10.3969/j.issn.1006-1959.2019.11.025]